Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
CUTR's Cash to Debt is ranked higher than
98% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. CUTR: No Debt )
Ranked among companies with meaningful Cash to Debt only.
CUTR' s Cash to Debt Range Over the Past 10 Years
Min: N/A  Med: No Debt Max: No Debt
Current: No Debt
N/A
No Debt
Equity to Asset 0.65
CUTR's Equity to Asset is ranked higher than
54% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. CUTR: 0.65 )
Ranked among companies with meaningful Equity to Asset only.
CUTR' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.82 Max: 0.87
Current: 0.65
0.31
0.87
Interest Coverage No Debt
CUTR's Interest Coverage is ranked higher than
98% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 73.78 vs. CUTR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
CUTR' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
F-Score: 8
Z-Score: 6.10
M-Score: -2.31
WACC vs ROIC
3.20%
-5.58%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -0.05
CUTR's Operating margin (%) is ranked lower than
54% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. CUTR: -0.05 )
Ranked among companies with meaningful Operating margin (%) only.
CUTR' s Operating margin (%) Range Over the Past 10 Years
Min: -20.83  Med: -7.94 Max: 9.39
Current: -0.05
-20.83
9.39
Net-margin (%) 0.38
CUTR's Net-margin (%) is ranked lower than
53% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. CUTR: 0.38 )
Ranked among companies with meaningful Net-margin (%) only.
CUTR' s Net-margin (%) Range Over the Past 10 Years
Min: -32.93  Med: -7.42 Max: 10.33
Current: 0.38
-32.93
10.33
ROE (%) 0.83
CUTR's ROE (%) is ranked lower than
52% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. CUTR: 0.83 )
Ranked among companies with meaningful ROE (%) only.
CUTR' s ROE (%) Range Over the Past 10 Years
Min: -16.6  Med: -6.99 Max: 9.59
Current: 0.83
-16.6
9.59
ROA (%) 0.54
CUTR's ROA (%) is ranked higher than
52% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. CUTR: 0.54 )
Ranked among companies with meaningful ROA (%) only.
CUTR' s ROA (%) Range Over the Past 10 Years
Min: -13.66  Med: -5.3 Max: 7.71
Current: 0.54
-13.66
7.71
ROC (Joel Greenblatt) (%) -1.17
CUTR's ROC (Joel Greenblatt) (%) is ranked lower than
53% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 3.44 vs. CUTR: -1.17 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CUTR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1247.08  Med: -223.26 Max: 140.19
Current: -1.17
-1247.08
140.19
Revenue Growth (3Y)(%) 7.40
CUTR's Revenue Growth (3Y)(%) is ranked higher than
65% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. CUTR: 7.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CUTR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.1  Med: 9.5 Max: 54.9
Current: 7.4
-18.1
54.9
EBITDA Growth (3Y)(%) -13.60
CUTR's EBITDA Growth (3Y)(%) is ranked lower than
77% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. CUTR: -13.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CUTR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -29  Med: 17.35 Max: 88.4
Current: -13.6
-29
88.4
EPS Growth (3Y)(%) -11.40
CUTR's EPS Growth (3Y)(%) is ranked lower than
71% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. CUTR: -11.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CUTR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -29.8  Med: 2.6 Max: 142.6
Current: -11.4
-29.8
142.6
» CUTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

CUTR Guru Trades in Q4 2015

Jim Simons 993,831 sh (+8.21%)
Mario Gabelli 605,000 sh (unchged)
» More
Q1 2016

CUTR Guru Trades in Q1 2016

Jim Simons 1,074,900 sh (+8.16%)
Mario Gabelli 605,000 sh (unchged)
» More
Q2 2016

CUTR Guru Trades in Q2 2016

Mario Gabelli 605,000 sh (unchged)
Jim Simons 1,025,800 sh (-4.57%)
» More
Q3 2016

CUTR Guru Trades in Q3 2016

Jim Simons 1,045,400 sh (+1.91%)
Mario Gabelli 605,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NYSE:GI, OTCBB:GTHPE, NAS:RTIX, NAS:IRIX, NAS:ELOS, NAS:ACRX, NAS:TCMD, NAS:CGNT, NAS:FONR, NAS:AXGN, NAS:PAVM, NAS:VRAY, NAS:IRMD, NAS:XENT, NAS:AVGR, NAS:DRAD, AMEX:CVRS, NAS:EDAP, NAS:EYES, OTCPK:QTVLF » details
Traded in other countries:TJ9.Germany,
Cutera Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners.

Cutera Inc was established in the San Francisco Bay Area in 1998. It is a medical device company, specializing in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. It offers easy-to-use products based on four main platforms/systems Xeo, GenesisPlus, ExcelV, and truSculpt, each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. The Xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. GenesisPlus platform, is a dedicated laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. ExcelV is a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award-winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. truSculpt is a high-powered radio frequency platform designed for the non-invasive body contouring market. This system is designed to treat all body areas and with its electrode design is able to achieve comfortable, uniform heating of the subcutaneous fat. In the U.S. its markets and sells its products mainly through a direct sales organization. International sales are generally made through a distributor network in over 60 countries. As of December 31, 2013, the Company had 30 issued U.S. patents and 11 pending U.S. patent applications. Its registered trademarks include Cutera, Acutip 500, CoolGlide, CoolGlide Excel, Limelight, myQ, Pearl, ProWave 770, ProWave LX, Solera, Titan, Xeo and truSculpt. The Company's products competes against laser and other energy-based products offered by public companies, such as Cynosure, Elen (in Italy), Lumenis, Syneron and Zeltiq, as well as private companies, including, Alma, Sciton, and several others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, as well as other regulatory bodies.

Ratios

vs
industry
vs
history
Forward P/E 29.76
CUTR's Forward P/E is ranked lower than
72% of the 54 Companies
in the Global Medical Devices industry.

( Industry Median: 21.74 vs. CUTR: 29.76 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 4.08
CUTR's P/B is ranked lower than
60% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. CUTR: 4.08 )
Ranked among companies with meaningful P/B only.
CUTR' s P/B Range Over the Past 10 Years
Min: 0.68  Med: 1.58 Max: 5.16
Current: 4.08
0.68
5.16
P/S 1.95
CUTR's P/S is ranked higher than
62% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.02 vs. CUTR: 1.95 )
Ranked among companies with meaningful P/S only.
CUTR' s P/S Range Over the Past 10 Years
Min: 0.93  Med: 1.96 Max: 7.7
Current: 1.95
0.93
7.7
PFCF 431.12
CUTR's PFCF is ranked lower than
98% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 26.13 vs. CUTR: 431.12 )
Ranked among companies with meaningful PFCF only.
CUTR' s PFCF Range Over the Past 10 Years
Min: 8.45  Med: 36.65 Max: 465.6
Current: 431.12
8.45
465.6
POCF 253.20
CUTR's POCF is ranked lower than
99% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 18.20 vs. CUTR: 253.20 )
Ranked among companies with meaningful POCF only.
CUTR' s POCF Range Over the Past 10 Years
Min: 8.11  Med: 35.28 Max: 633
Current: 253.2
8.11
633
EV-to-EBITDA 175.28
CUTR's EV-to-EBITDA is ranked lower than
95% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 16.23 vs. CUTR: 175.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
CUTR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -503.2  Med: -3.5 Max: 185.2
Current: 175.28
-503.2
185.2
Current Ratio 2.92
CUTR's Current Ratio is ranked higher than
57% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. CUTR: 2.92 )
Ranked among companies with meaningful Current Ratio only.
CUTR' s Current Ratio Range Over the Past 10 Years
Min: 2.5  Med: 6.68 Max: 9.09
Current: 2.92
2.5
9.09
Quick Ratio 2.30
CUTR's Quick Ratio is ranked higher than
59% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. CUTR: 2.30 )
Ranked among companies with meaningful Quick Ratio only.
CUTR' s Quick Ratio Range Over the Past 10 Years
Min: 2.21  Med: 6.1 Max: 8.66
Current: 2.3
2.21
8.66
Days Inventory 111.17
CUTR's Days Inventory is ranked higher than
60% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 134.83 vs. CUTR: 111.17 )
Ranked among companies with meaningful Days Inventory only.
CUTR' s Days Inventory Range Over the Past 10 Years
Min: 63.96  Med: 104.48 Max: 137.01
Current: 111.17
63.96
137.01
Days Sales Outstanding 38.68
CUTR's Days Sales Outstanding is ranked higher than
87% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 66.89 vs. CUTR: 38.68 )
Ranked among companies with meaningful Days Sales Outstanding only.
CUTR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.62  Med: 36.58 Max: 52.02
Current: 38.68
22.62
52.02
Days Payable 25.99
CUTR's Days Payable is ranked lower than
82% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. CUTR: 25.99 )
Ranked among companies with meaningful Days Payable only.
CUTR' s Days Payable Range Over the Past 10 Years
Min: 17.66  Med: 21.02 Max: 36.15
Current: 25.99
17.66
36.15

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 3.00
CUTR's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. CUTR: 3.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CUTR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.6  Med: -2.6 Max: 3
Current: 3
-13.6
3

Valuation & Return

vs
industry
vs
history
Price/Net Cash 12.37
CUTR's Price/Net Cash is ranked higher than
61% of the 98 Companies
in the Global Medical Devices industry.

( Industry Median: 16.84 vs. CUTR: 12.37 )
Ranked among companies with meaningful Price/Net Cash only.
CUTR' s Price/Net Cash Range Over the Past 10 Years
Min: 1.2  Med: 2.6 Max: 12.37
Current: 12.37
1.2
12.37
Price/Net Current Asset Value 4.54
CUTR's Price/Net Current Asset Value is ranked higher than
69% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 6.51 vs. CUTR: 4.54 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
CUTR' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.91  Med: 1.93 Max: 23.73
Current: 4.54
0.91
23.73
Price/Tangible Book 4.32
CUTR's Price/Tangible Book is ranked lower than
52% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 4.06 vs. CUTR: 4.32 )
Ranked among companies with meaningful Price/Tangible Book only.
CUTR' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.77  Med: 1.89 Max: 20.68
Current: 4.32
0.77
20.68
Price/Projected FCF 24.92
CUTR's Price/Projected FCF is ranked lower than
98% of the 124 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. CUTR: 24.92 )
Ranked among companies with meaningful Price/Projected FCF only.
CUTR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.45  Med: 1.42 Max: 1308
Current: 24.92
0.45
1308
Price/Median PS Value 1.02
CUTR's Price/Median PS Value is ranked higher than
53% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. CUTR: 1.02 )
Ranked among companies with meaningful Price/Median PS Value only.
CUTR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.56  Med: 1.07 Max: 2.6
Current: 1.02
0.56
2.6

More Statistics

Revenue (TTM) (Mil) $110.2
Beta0.11
Short Percentage of Float1.48%
52-Week Range $9.83 - 17.20
Shares Outstanding (Mil)13.41

Analyst Estimate

Dec16 Dec17 Dec18 Dec19
Revenue (Mil $) 116 130 146 163
EPS ($) 0.45 0.55 0.70 0.90
EPS w/o NRI ($) 0.45 0.55 0.70 0.90
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for CUTR

Headlines

Articles On GuruFocus.com
Chuck Royce's Top Five Second Quarter Portfolio Increases Aug 07 2013 
Gurus Buy Micro Caps – Bamboo Toilet Paper Jul 24 2013 
Guru Weekly Real Time Update Jul 05 2013 
Mario Gabelli and Jean-Marie Eveillard's Real Time Increases Jul 02 2013 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 

More From Other Websites
ETFs with exposure to Cutera, Inc. : November 29, 2016 Nov 29 2016
8 Stocks with Recent Price Strength for Solid Returns Nov 29 2016
Cutera, Inc. :CUTR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 Nov 28 2016
Top Ranked Momentum Stocks to Buy for November 23rd Nov 23 2016
Why Cutera (CUTR) Could Shock the Market Soon Nov 22 2016
Top Ranked Momentum Stocks to Buy for November 22nd Nov 22 2016
Strength Seen in Cutera (CUTR): Stock Adds 5.8% in Session Nov 22 2016
CUTERA INC Financials Nov 16 2016
Edited Transcript of CUTR earnings conference call or presentation 7-Nov-16 10:00pm GMT Nov 07 2016
Cutera posts 3Q profit Nov 07 2016
Cutera posts 3Q profit Nov 07 2016
Cutera Inc Earnings Call scheduled for 5:00 pm ET today Nov 07 2016
CUTERA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 07 2016
Cutera Elects J. Daniel Plants as Chairman of the Board Nov 07 2016
Cutera Reports Record Third Quarter 2016 Results Nov 07 2016
Q3 2016 Cutera Inc Earnings Release - After Market Close Nov 07 2016
CUTERA INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 03 2016
Cutera, Inc. to Announce Results for the Third Quarter Ended September 30, 2016 Nov 03 2016
Cutera Elects J. Daniel Plants as Chairman of the Board Nov 03 2016
Cutera to Present at Two Upcoming Investor Conferences Oct 26 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)